Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YM178 in Overactive Bladder
NCT00966004Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2009
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mirabegron in overactive bladder (OAB), sponsored by Astellas Pharma. Started Jul 2009; status: completed.
02
Drugs
mirabegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00966004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00966004.